© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to March
GLP-1R/GLP molecular glue agonist (PAM)
oral blood glucose↓, additive w/ sitaglipin
from 220k cmpd cell-based screen + PK opt.
J. Med. Chem., Mar. 15, 2021
Lilly Research Laboratories, Indianapolis, IN
1.The Lilly glucagon-like peptide-1 receptor (GLP-1R) agonist (LSN3318839) is a positive allosteric modulator intended to treat type 2 diabetes. This drug candidate has an interesting proposed mechanism as a…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.